] Total protein (10 µg) was separated by SDS‐PAGE and transferred to a PVDF membrane (Bio‐Rad). The membrane was incubated with primary antibodies, and the protein was visualized with ECL (HRP) (Millipore). The following antibodies were used for western blot analysis: anti‐Pten (Cell Signaling Technology, 9188), anti‐β‐actin (Immunoway, YM3028), anti‐p‐T308‐Akt (Cell Signaling Technology, 13038), anti‐p‐S473‐Akt (Cell Signaling Technology, 4060), anti‐Akt (Cell Signaling Technology, 4691), anti‐cTnT (Abcam, ab8295), anti‐Dnmt3l (Cell Signaling Technology, 13451), anti‐Dnmt3b (Cell Signaling Technology, 48488), anti‐Dnmt3b (ab122932, Abcam), anti‐Igf1r (Cell Signaling Technology, 3027), anti‐p‐S253‐FoxO3a (Abcam, ab47285), anti‐p‐T32‐FoxO3a (Cell Signaling Technology, 9464), anti‐FoxO3a (Cell Signaling Technology, 2497), anti‐Phospho‐p44/42 MAPK (Erk1/2) (Cell Signaling Technology, 4370), anti‐ Insulin Receptor β (Abcam, ab69508), anti‐p44/42 MAPK (Erk1/2) (Cell Signaling Technology, 4695), anti‐β‐Tubulin (Cell Signaling Technology, 2146), and anti‐Lamin A/C (Cell Signaling Technology, 4777).
Western Blot Analysis of Protein Expression
] Total protein (10 µg) was separated by SDS‐PAGE and transferred to a PVDF membrane (Bio‐Rad). The membrane was incubated with primary antibodies, and the protein was visualized with ECL (HRP) (Millipore). The following antibodies were used for western blot analysis: anti‐Pten (Cell Signaling Technology, 9188), anti‐β‐actin (Immunoway, YM3028), anti‐p‐T308‐Akt (Cell Signaling Technology, 13038), anti‐p‐S473‐Akt (Cell Signaling Technology, 4060), anti‐Akt (Cell Signaling Technology, 4691), anti‐cTnT (Abcam, ab8295), anti‐Dnmt3l (Cell Signaling Technology, 13451), anti‐Dnmt3b (Cell Signaling Technology, 48488), anti‐Dnmt3b (ab122932, Abcam), anti‐Igf1r (Cell Signaling Technology, 3027), anti‐p‐S253‐FoxO3a (Abcam, ab47285), anti‐p‐T32‐FoxO3a (Cell Signaling Technology, 9464), anti‐FoxO3a (Cell Signaling Technology, 2497), anti‐Phospho‐p44/42 MAPK (Erk1/2) (Cell Signaling Technology, 4370), anti‐ Insulin Receptor β (Abcam, ab69508), anti‐p44/42 MAPK (Erk1/2) (Cell Signaling Technology, 4695), anti‐β‐Tubulin (Cell Signaling Technology, 2146), and anti‐Lamin A/C (Cell Signaling Technology, 4777).
Corresponding Organization : Chinese University of Hong Kong
Other organizations : Hong Kong Science and Technology Parks Corporation, Hai Kang Life (China)
Variable analysis
- None explicitly mentioned
- β-actin
- P-T308-Akt
- P-S473-Akt
- Dnmt3l
- Dnmt3b
- Igf1r
- P-S253-FoxO3a
- P-T32-FoxO3a
- FoxO3a
- Phospho-p44/42 MAPK (Erk1/2)
- Insulin Receptor β
- P44/42 MAPK (Erk1/2)
- β-Tubulin
- Lamin A/C
- Cells were scraped from culture plates and incubated for 20 min in ice‐cold lysis buffer containing protease inhibitor cocktails
- Nuclear and cytoplasmic fractions were prepared as described previously
- None explicitly mentioned
- None explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!